首页> 中文期刊> 《亚洲社会药学》 >Research and Reference of the Authorized Generic Drug System in the US

Research and Reference of the Authorized Generic Drug System in the US

         

摘要

Objective To study the significance of authorized generic drugs due to the successive relevant documents issued by China’s government in recent years,which clearly stipulated that China should establish a drug patent linkage system.Methods The authorized generic drugs play an important role in keeping the balance between brandname drugs and generic drugs in the US.Therefore,this system was investigated,focusing on its difference from independent generics,marketing procedures,application in patent litigation and legitimacy analysis through case evidence.This analogy analysis could provide a reference for the research of authorized generic drug systems in China.Results and Conclusion As an important factor affecting the balance between brand-name drugs and generic drugs,authorized generic drugs should be comprehensively analyzed and discussed,and a suitable system for China’s national conditions should be established by referring to the experiences of the US.

著录项

  • 来源
    《亚洲社会药学》 |2021年第1期|P.11-22|共12页
  • 作者

    Wang Hongwei; Yang Yue;

  • 作者单位

    School of Business Administration Shenyang Pharmaceutical University Shenyang 110016 ChinaInternational Center for Food and Drug Policy and Law Research Shenyang Pharmaceutical University Shenyang 110016 China;

    School of Business Administration Shenyang Pharmaceutical University Shenyang 110016 ChinaInternational Center for Food and Drug Policy and Law Research Shenyang Pharmaceutical University Shenyang 110016 China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 数学分析;
  • 关键词

    authorized generic drug; patent linkage system; drug; settlement; patent litigation;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号